EV/EBITDA
-0.53
+0.01+1.85%
Wed, 12 Mar 2025 13:30:00 GMT
Summary
- As of March 14, 2025, CTCX EV/EBITDA is -0.53, with a rise of +0.01 (+1.85%) during the most recent trading day.
- Over the past year, CTCX EV/EBITDA has increased by +2.99 (+84.94%).
- CTCX EV/EBITDA is now -65.63% below its all-time high of -0.32.
Performance
CTCX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
CTCX EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | +1.9% | -2.1% | -2.0% |
1 m1 month | -8.2% | +7.9% | +7.3% |
3 m3 months | -17.8% | +18.5% | +17.1% |
6 m6 months | +3.6% | -40.3% | -45.2% |
ytdytd | +8.6% | -8.5% | -8.0% |
1 y1 year | +84.9% | -90.6% | -89.0% |
5 y5 years | - | - | - |
CTCX EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -35.9% | -0.67 | +20.9% | |
3 m | 3-month | -0.39 | -35.9% | -1.34 | +60.5% |
6 m | 6-month | -0.32 | -65.6% | -1.46 | +63.7% |
1 y | 1-year | -0.32 | -65.6% | -4.58 | +88.4% |
3 y | 3-year | -0.32 | -65.6% | -13.62 | +96.1% |
5 y | 5-year | -0.32 | -65.6% | -13.62 | +96.1% |
alltime | all time | -0.32 | -65.6% | -13.62 | +96.1% |
Carmell Therapeutics EV/EBITDA History
Date | Value |
---|---|
2025 | -0.53(-8.6%) |
Date | Value |
---|---|
2024 | -0.58(-89.9%) |
2023 | -5.77 |
FAQ
- What is Carmell Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Carmell Therapeutics?
- What is CTCX EV/EBITDA year-to-date change?
- What is Carmell Therapeutics EV/EBITDA year-on-year change?
What is Carmell Therapeutics EV/EBITDA?
The current EV/EBITDA of CTCX is -0.53
What is the all time high EV/EBITDA for Carmell Therapeutics?
Carmell Therapeutics all-time high EV/EBITDA is -0.32
What is CTCX EV/EBITDA year-to-date change?
Carmell Therapeutics EV/EBITDA has changed by +0.05 (+8.62%) since the beginning of the year
What is Carmell Therapeutics EV/EBITDA year-on-year change?
Over the past year, CTCX EV/EBITDA has changed by +2.99 (+84.94%)